Gene · 2328
Papers1,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biochemical and genetic biomarkers associated with nicotine dependence in Mexican smokers. | Pharmacol Res Perspect | 2023 | 37787014 | PubTator, text mining | PubMed |
| The long non-coding RNA LINC00707 interacts with Smad proteins to regulate TGFβ signaling and cancer cell invasion. | Cell Commun Signal | 2023 | 37784093 | PubTator, text mining | PubMed |
| Metaorganismal choline metabolism shapes olfactory perception. | J Biol Chem | 2023 | 37777156 | PubTator, text mining | PubMed |
| Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS. | Thorac Cancer | 2023 | 37771131 | PubTator, text mining | PubMed |
| Insights into the Relationship between the Microstructure and the Catalytic Behavior of Fe2(MoO4)3 during the Ethanolysis of Naomaohu Coal. | Molecules | 2023 | 37764371 | PubTator, text mining | PubMed |
| The presence of busulfan metabolites and pharmacometabolomics in plasma drawn immediately before allograft infusion in hematopoietic cell transplant recipients. | Clin Transl Sci | 2023 | 37749994 | PubTator, text mining | PubMed |
| Improving the accuracy of the FMO binding affinity prediction of ligand-receptor complexes containing metals. | J Comput Aided Mol Des | 2023 | 37743428 | PubTator, text mining | PubMed |
| Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis. | Front Pharmacol | 2023 | 37719851 | PubTator, text mining | PubMed |
| Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins. | Curr Atheroscler Rep | 2023 | 37702886 | PubTator, text mining | PubMed |
| Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease. | Lipids Health Dis | 2023 | 37697333 | PubTator, text mining | PubMed |
| The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals. | Front Genet | 2023 | 37693307 | PubTator, text mining | PubMed |
| The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease. | Microorganisms | 2023 | 37630619 | PubTator, text mining | PubMed |
| Recent Advances in Microbiota-Associated Metabolites in Heart Failure. | Biomedicines | 2023 | 37626809 | PubTator, text mining | PubMed |
| Evaluating Alterations of the Oral Microbiome and Its Link to Oral Cancer among Betel Quid Chewers: Prospecting Reversal through Probiotic Intervention. | Pathogens | 2023 | 37623956 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients. | Open Life Sci | 2023 | 37589009 | PubTator, text mining | PubMed |
| Optimization of enzyme-linked immunosorbent assay kit protocol to detect trimethylamine N-oxide levels in humans. | EXCLI J | 2023 | 37575362 | PubTator, text mining | PubMed |
| Targeting metabolism in aortic aneurysm and dissection: from basic research to clinical applications. | Int J Biol Sci | 2023 | 37564200 | PubTator, text mining | PubMed |
| Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review. | Cureus | 2023 | 37554593 | PubTator, text mining | PubMed |
| Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3. | J Nutr Biochem | 2023 | 37549832 | PubTator, text mining | PubMed |
| Plant-Based Nutrition: Exploring Health Benefits for Atherosclerosis, Chronic Diseases, and Metabolic Syndrome-A Comprehensive Review. | Nutrients | 2023 | 37513660 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2328/papers?page=8